Raptiva

The plaque psoriasis drug Raptiva (efalizumab) was recently issued a 'black box' warning from the Food and Drug Administration (FDA), the strongest warning possible.  Raptiva has been associated with dangerous, opportunistic infections, including meningitis, progressive multifocal leukoencephalopathy (PML) - an exceedingly dangerous brain infection, and resulting deaths.

Raptiva is designed to limit the immune system with the goal of alleviating psoriasis.  With a limited immune system, patients are subjected to an unnecessarily high risk of disease and infection.  In February, the European Medicines Agency (the European Union's FDA equivalent) recommended the complete suspension of Raptiva sales, stating the benefits of the drug do not outweigh the risks.

If you or a loved one has been injured while taking Raptiva, The Law Offices of Larry H. Parker can help.  We are a highly recognized legal practice with the ability and know how to handle your pharmaceutical case successfully.  Larry's knowledgeable team of attorneys has already crafted a history of successful case resolutions.  To schedule a free, confidential, no obligation consultation, call us at (800) 333-0000 or submit a case form.  With us you aren't charged a dime if we don't get you any money.  The Law Offices of Larry H. Parker handles pharmaceutical cases nationally, with offices in Long Beach, Los Angeles, Riverside, and Fresno, California and Phoenix and Tucson, Arizona.  Tough times call for tough lawyers.  We'll fight for you!

Raptiva® is a registered trademark of Genentech, Inc.